Machine learning for comprehensive prediction of high risk for Alzheimer’s disease based on chromatic pupilloperimetry

Wimo, A. et al. The worldwide economic impact of dementia 2010. Alzheimers Dement. 9, 1-11.e3 (2013).

PubMed 
Article 

Google Scholar 

Dunn, B., Stein, P. & Cavazzoni, P. Approval of aducanumab for Alzheimer disease-the FDA’s perspective. JAMA Intern. Med. 181, 1276–1278 (2021).

PubMed 
Article 
CAS 

Google Scholar 

Hsu, D. & Marshall, G. A. Primary and secondary prevention trials in Alzheimer disease: Looking back, moving forward. Curr. Alzheimer Res. 14, 426–440 (2017).

CAS 
PubMed 
PubMed Central 
Article 

Google Scholar 

Cummings, J. L., Doody, R. & Clark, C. Disease-modifying therapies for Alzheimer disease: Challenges to early intervention. Neurology 69, 1622–1634 (2007).

PubMed 
Article 

…